Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series (Q36806851)

16 August 2017

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series (English)

1 reference

enzyme replacement therapy

16 August 2017

0 references

mucopolysaccharidosis VI

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Wuh-liang Hwu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

6

Fuu-Jen Tsai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

8

Shio Jean Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

13

Shuan-Pei Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

2

Chih-Kuang Chuang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

9

Hui-Ping Pan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

10

Dau-Ming Niu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

7

Yen-Yin Chou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Hsiang-Yu Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Chung-Hsing Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Yu-Mei Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Yu-Yuan Ke

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

18 April 2016

1 reference

Molecular Genetics and Metabolism Reports

16 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

63-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis

5 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Mucopolysaccharidosis VI: the Italian experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Otorhinolaryngological manifestations of the mucopolysaccharidoses.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Standardization of Spirometry, 1994 Update. American Thoracic Society

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Up to five years experience with 11 mucopolysaccharidosis type VI patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP).

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Left ventricular mass in 169 healthy children and young adults assessed by three-dimensional echocardiography.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4834679

Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004

20 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

Measurement of health status in children with juvenile rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

Enzyme replacement therapy for mucopolysaccharidosis VI—experience in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age--a sibling control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.04.003

The health assessment questionnaire 1992: status and review

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27134829

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YMGMR.2016.04.003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference